S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines
暂无分享,去创建一个
E. Rappaport | N. Ikegaki | S. Hicks | Paul L. Regan | Joshua Jacobs | Xao X. Tang | Amina S. Jumbo | Payton Leonhardt | Xao X. Tang
[1] E. Rappaport,et al. Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas , 2013, Proceedings of the National Academy of Sciences.
[2] T. Anthony,et al. ATF4-dependent Regulation of the JMJD3 Gene during Amino Acid Deprivation Can Be Rescued in Atf4-deficient Cells by Inhibition of Deacetylation* , 2012, The Journal of Biological Chemistry.
[3] R. Eisenman,et al. Post-translational control of Myc function during differentiation , 2011, Cell cycle.
[4] Gerald Wang,et al. Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma. , 2010, International journal of oncology.
[5] E. Rappaport,et al. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. , 2010, International Journal of Oncology.
[6] R. Eisenman,et al. Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation , 2010, Cell.
[7] R. Spielman,et al. Gene expression and genetic variation in response to endoplasmic reticulum stress in human cells. , 2010, American Journal of Human Genetics.
[8] N. Ikegaki,et al. Biological significance of EPHA2 expression in neuroblastoma. , 2009, International journal of oncology.
[9] John M. Maris,et al. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma , 2008, Proceedings of the National Academy of Sciences.
[10] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[11] Fatima S. Khwaja,et al. The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. , 2007, Cancer research.
[12] E. May,et al. Expression of C-terminal deleted p53 isoforms in neuroblastoma , 2006, Nucleic acids research.
[13] N. Cheung,et al. The MYCN enigma: significance of MYCN expression in neuroblastoma. , 2006, Cancer research.
[14] P. Kogner,et al. Cyclooxygenase-2 Is Expressed in Neuroblastoma, and Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis and Inhibit Tumor Growth In vivo , 2004, Cancer Research.
[15] Hye-Jin Hwang,et al. Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis , 2004, Cell Death and Differentiation.
[16] M. E. Robinson,et al. Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma , 2004, Clinical Cancer Research.
[17] Fatima S. Khwaja,et al. Ibuprofen Inhibits Survival of Bladder Cancer Cells by Induced Expression of the p75NTR Tumor Suppressor Protein , 2004, Cancer Research.
[18] R. Gentleman,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[19] Chi Li,et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis , 2003, The Journal of cell biology.
[20] Tullio Pozzan,et al. BAX and BAK Regulation of Endoplasmic Reticulum Ca2+: A Control Point for Apoptosis , 2003, Science.
[21] W. Phleps. Overview on Clinical Data of Dexibuprofen , 2001, Clinical Rheumatology.
[22] Kyong-Tai Kim,et al. Potentiation of PGE2‐mediated cAMP production during neuronal differentiation of human neuroblastoma SK‐N‐BE(2)C cells , 2001, Journal of neurochemistry.
[23] M. E. Robinson,et al. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. DuBois,et al. The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.
[25] A. Cnaan,et al. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[27] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[28] R. Kennett,et al. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Sather,et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.
[30] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[31] R. Arceci. The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report , 2009 .
[32] J. Lunec,et al. Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. , 2001, Cancer research.